Stay updated on Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page header. This appears to be a site version update and does not alter the trial content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded revision: v3.4.2 and removed the funding lapse and government operating status notices (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedA site-wide notice about a lapse in government funding affecting data currency has been added, and the page now shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded a 'Show glossary' option and made minor metadata label changes (capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), with the revision header updated to v3.4.0.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.